תוצאות חיפוש - Mary Ellen Simcox

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer

    Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer מאת Hong Yang, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, William D. Bradley, Richard J. Lee, Kathleen Schostack, Mary Ellen Simcox, Scott Kopetz, David Heimbrook, Brian Lestini, Gideon Bollag, Fei Su

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

    RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models מאת Hong Yang, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, Zenaida Go, Raman Iyer, Stanley P. Kolis, Sylvia Zhao, Richard Lee, Joseph F. Grippo, Kathleen Schostack, Mary Ellen Simcox, David Heimbrook, Gideon Bollag, Fei Su

    יצא לאור 2010
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation

    Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation מאת Fei Su, William D. Bradley, Qiongqing Wang, Hong Yang, Lizhong Xu, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, Min Jung Kim, Kerstin Trunzer, Richard J. Lee, Kathleen Schostack, Jade Carter, Thomas Albert, Søren Germer, Jim Rosinski, Mitchell Martin, Mary Ellen Simcox, Brian Lestini, David Heimbrook, Gideon Bollag

    יצא לאור 2011
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies

    CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies מאת Steven N. Quayle, Natasha Girgis, Dharma R. Thapa, Zohra Merazga, Melissa M. Kemp, Alex Histed, Fan Zhao, Miguel Moreta, Paige Ruthardt, Sandrine Hulot, Alyssa Nelson, Lauren D. Kraemer, Dominic R. Beal, Luke Witt, Jessica Ryabin, Jonathan Soriano, Mark Haydock, Emily Spaulding, John F. Ross, Peter A. Kiener, Steven C. Almo, Rodolfo Chaparro, R.D. Seidel, Anish Suri, Sašo Čemerski, Kenneth J. Pienta, Mary Ellen Simcox

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Molecular basis of USP7 inhibition by selective small-molecule inhibitors

    Molecular basis of USP7 inhibition by selective small-molecule inhibitors מאת A.P. Turnbull, Stephanos Ioannidis, Wojciech Krajewski, Adán Pinto-Fernández, Claire Heride, Agnés C. L. Martin, Louise M. Tonkin, Elizabeth C. Townsend, Shane M. Buker, David R. Lancia, Justin A. Caravella, Angela V. Toms, Thomas M. Charlton, Johanna Lahdenranta, Erik Wilker, Bruce Follows, Nicola J. Evans, Lucy F. Stead, Cristina Alli, Vladislav Zarayskiy, Adam C. Talbot, Alexandre J. Buckmelter, Minghua Wang, Crystal McKinnon, Fabienne Saab, Joanna F. McGouran, Hannah Century, Malte Gersch, Marc S. Pittman, C. Gary Marshall, Tony Raynham, Mary Ellen Simcox, Lorna Stewart, Sheila B. McLoughlin, Jaime A. Escobedo, Kenneth W. Bair, Christopher J. Dinsmore, Tim Hammonds, Sunkyu Kim, Sylvie Urbé, Michael J. Clague, Benedikt M. Kessler, David Komander

    יצא לאור 2017
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: